June 2, 2020 / 6:28 PM / a month ago

CORRECTED-BRIEF-FDA Authorizes OPKO Health Clinical Trial Evaluating Rayaldee In Covid-19 Patients (June 1)

(Corrects headline on June 1 brief item to OPKO from OKPK)

June 1 (Reuters) - OPKO Health Inc:

* FDA AUTHORIZES OPKO HEALTH CLINICAL TRIAL EVALUATING RAYALDEE IN COVID-19 PATIENTS

* OPKO HEALTH - FDA HAS AUTHORIZED OPKO TO UNDERTAKE PHASE 2 TRIAL WITH RAYALDEE AS TREATMENT FOR PATIENTS WITH MILD-TO-MODERATE COVID-19 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below